
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Harnessing the biology of IL-7 for therapeutic application
Crystal L. Mackall, Terry J. Fry, Ronald E. Gress
Nature reviews. Immunology (2011) Vol. 11, Iss. 5, pp. 330-342
Open Access | Times Cited: 518
Crystal L. Mackall, Terry J. Fry, Ronald E. Gress
Nature reviews. Immunology (2011) Vol. 11, Iss. 5, pp. 330-342
Open Access | Times Cited: 518
Showing 1-25 of 518 citing articles:
Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy
Richard S. Hotchkiss, Guillaume Monneret, Didier Payen
Nature reviews. Immunology (2013) Vol. 13, Iss. 12, pp. 862-874
Open Access | Times Cited: 2161
Richard S. Hotchkiss, Guillaume Monneret, Didier Payen
Nature reviews. Immunology (2013) Vol. 13, Iss. 12, pp. 862-874
Open Access | Times Cited: 2161
Adoptive immunotherapy for cancer: harnessing the T cell response
Nicholas P. Restifo, Mark E. Dudley, Steven A. Rosenberg
Nature reviews. Immunology (2012) Vol. 12, Iss. 4, pp. 269-281
Open Access | Times Cited: 1587
Nicholas P. Restifo, Mark E. Dudley, Steven A. Rosenberg
Nature reviews. Immunology (2012) Vol. 12, Iss. 4, pp. 269-281
Open Access | Times Cited: 1587
The immunopathology of sepsis and potential therapeutic targets
Tom van der Poll, Frank L. van de Veerdonk, Brendon P. Scicluna, et al.
Nature reviews. Immunology (2017) Vol. 17, Iss. 7, pp. 407-420
Closed Access | Times Cited: 1456
Tom van der Poll, Frank L. van de Veerdonk, Brendon P. Scicluna, et al.
Nature reviews. Immunology (2017) Vol. 17, Iss. 7, pp. 407-420
Closed Access | Times Cited: 1456
Immunosuppression in sepsis: a novel understanding of the disorder and a new therapeutic approach
Richard S. Hotchkiss, Guillaume Monneret, Didier Payen
The Lancet Infectious Diseases (2013) Vol. 13, Iss. 3, pp. 260-268
Open Access | Times Cited: 1282
Richard S. Hotchkiss, Guillaume Monneret, Didier Payen
The Lancet Infectious Diseases (2013) Vol. 13, Iss. 3, pp. 260-268
Open Access | Times Cited: 1282
Sepsis and septic shock
Richard S. Hotchkiss, Lyle L. Moldawer, Steven M. Opal, et al.
Nature Reviews Disease Primers (2016) Vol. 2, Iss. 1
Open Access | Times Cited: 1269
Richard S. Hotchkiss, Lyle L. Moldawer, Steven M. Opal, et al.
Nature Reviews Disease Primers (2016) Vol. 2, Iss. 1
Open Access | Times Cited: 1269
Advances in the understanding and treatment of sepsis-induced immunosuppression
Fabienne Venet, Guillaume Monneret
Nature Reviews Nephrology (2017) Vol. 14, Iss. 2, pp. 121-137
Open Access | Times Cited: 687
Fabienne Venet, Guillaume Monneret
Nature Reviews Nephrology (2017) Vol. 14, Iss. 2, pp. 121-137
Open Access | Times Cited: 687
The immune system's role in sepsis progression, resolution, and long‐term outcome
Matthew J. Delano, Peter A. Ward
Immunological Reviews (2016) Vol. 274, Iss. 1, pp. 330-353
Open Access | Times Cited: 669
Matthew J. Delano, Peter A. Ward
Immunological Reviews (2016) Vol. 274, Iss. 1, pp. 330-353
Open Access | Times Cited: 669
Cytokines in Cancer Immunotherapy
Sylvia Lee, Kim Margolin
Cancers (2011) Vol. 3, Iss. 4, pp. 3856-3893
Open Access | Times Cited: 645
Sylvia Lee, Kim Margolin
Cancers (2011) Vol. 3, Iss. 4, pp. 3856-3893
Open Access | Times Cited: 645
Host-directed therapies for bacterial and viral infections
Stefan H. E. Kaufmann, Anca Dorhoi, Richard S. Hotchkiss, et al.
Nature Reviews Drug Discovery (2017) Vol. 17, Iss. 1, pp. 35-56
Open Access | Times Cited: 610
Stefan H. E. Kaufmann, Anca Dorhoi, Richard S. Hotchkiss, et al.
Nature Reviews Drug Discovery (2017) Vol. 17, Iss. 1, pp. 35-56
Open Access | Times Cited: 610
Sepsis-induced immune dysfunction: can immune therapies reduce mortality?
Matthew J. Delano, Peter A. Ward
Journal of Clinical Investigation (2016) Vol. 126, Iss. 1, pp. 23-31
Open Access | Times Cited: 549
Matthew J. Delano, Peter A. Ward
Journal of Clinical Investigation (2016) Vol. 126, Iss. 1, pp. 23-31
Open Access | Times Cited: 549
Cancer immunotherapy strategies based on overcoming barriers within the tumor microenvironment
Thomas F. Gajewski, Seng‐Ryong Woo, Yuanyuan Zha, et al.
Current Opinion in Immunology (2013) Vol. 25, Iss. 2, pp. 268-276
Closed Access | Times Cited: 396
Thomas F. Gajewski, Seng‐Ryong Woo, Yuanyuan Zha, et al.
Current Opinion in Immunology (2013) Vol. 25, Iss. 2, pp. 268-276
Closed Access | Times Cited: 396
Interleukin-7 restores lymphocytes in septic shock: the IRIS-7 randomized clinical trial
Bruno François, Robin Jeannet, Thomas Daix, et al.
JCI Insight (2018) Vol. 3, Iss. 5
Open Access | Times Cited: 325
Bruno François, Robin Jeannet, Thomas Daix, et al.
JCI Insight (2018) Vol. 3, Iss. 5
Open Access | Times Cited: 325
Contributions of Age-Related Thymic Involution to Immunosenescence and Inflammaging
Rachel Thomas, Weikan Wang, Dong‐Ming Su
Immunity & Ageing (2020) Vol. 17, Iss. 1
Open Access | Times Cited: 309
Rachel Thomas, Weikan Wang, Dong‐Ming Su
Immunity & Ageing (2020) Vol. 17, Iss. 1
Open Access | Times Cited: 309
The γc Family of Cytokines: Basic Biology to Therapeutic Ramifications
Warren J. Leonard, Jian‐Xin Lin, John J. O’Shea
Immunity (2019) Vol. 50, Iss. 4, pp. 832-850
Open Access | Times Cited: 302
Warren J. Leonard, Jian‐Xin Lin, John J. O’Shea
Immunity (2019) Vol. 50, Iss. 4, pp. 832-850
Open Access | Times Cited: 302
Host-directed therapies for infectious diseases: current status, recent progress, and future prospects
Alimuddin Zumla, Martin Rao, Robert S. Wallis, et al.
The Lancet Infectious Diseases (2016) Vol. 16, Iss. 4, pp. e47-e63
Open Access | Times Cited: 301
Alimuddin Zumla, Martin Rao, Robert S. Wallis, et al.
The Lancet Infectious Diseases (2016) Vol. 16, Iss. 4, pp. e47-e63
Open Access | Times Cited: 301
Barriers to a cure for HIV: new ways to target and eradicate HIV-1 reservoirs
Christine Katlama, Steven G. Deeks, Brigitte Autran, et al.
The Lancet (2013) Vol. 381, Iss. 9883, pp. 2109-2117
Open Access | Times Cited: 288
Christine Katlama, Steven G. Deeks, Brigitte Autran, et al.
The Lancet (2013) Vol. 381, Iss. 9883, pp. 2109-2117
Open Access | Times Cited: 288
T Cell Replicative Senescence in Human Aging
Jennifer Chou, Rita B. Effros
Current Pharmaceutical Design (2013) Vol. 19, Iss. 9, pp. 1680-1698
Open Access | Times Cited: 275
Jennifer Chou, Rita B. Effros
Current Pharmaceutical Design (2013) Vol. 19, Iss. 9, pp. 1680-1698
Open Access | Times Cited: 275
Therapeutic Cancer Vaccines: Current Status and Moving Forward
J Schlom
JNCI Journal of the National Cancer Institute (2012) Vol. 104, Iss. 8, pp. 599-613
Open Access | Times Cited: 271
J Schlom
JNCI Journal of the National Cancer Institute (2012) Vol. 104, Iss. 8, pp. 599-613
Open Access | Times Cited: 271
Pathological alteration and therapeutic implications of sepsis-induced immune cell apoptosis
Chao Cao, Muming Yu, Yanfen Chai
Cell Death and Disease (2019) Vol. 10, Iss. 10
Open Access | Times Cited: 270
Chao Cao, Muming Yu, Yanfen Chai
Cell Death and Disease (2019) Vol. 10, Iss. 10
Open Access | Times Cited: 270
Progressive multifocal leukoencephalopathy and the spectrum of JC virus-related disease
Irene Cortese, Daniel S. Reich, Avindra Nath
Nature Reviews Neurology (2020) Vol. 17, Iss. 1, pp. 37-51
Open Access | Times Cited: 267
Irene Cortese, Daniel S. Reich, Avindra Nath
Nature Reviews Neurology (2020) Vol. 17, Iss. 1, pp. 37-51
Open Access | Times Cited: 267
Genome-wide Association Study Identifies TNFSF15 and POU2AF1 as Susceptibility Loci for Primary Biliary Cirrhosis in the Japanese Population
Minoru Nakamura, Nao Nishida, Minae Kawashima, et al.
The American Journal of Human Genetics (2012) Vol. 91, Iss. 4, pp. 721-728
Open Access | Times Cited: 262
Minoru Nakamura, Nao Nishida, Minae Kawashima, et al.
The American Journal of Human Genetics (2012) Vol. 91, Iss. 4, pp. 721-728
Open Access | Times Cited: 262
Lymphopenia in Cancer Patients and its Effects on Response to Immunotherapy: an opportunity for combination with Cytokines?
Christine Ménétrier‐Caux, Isabelle Ray‐Coquard, Jean‐Yves Blay, et al.
Journal for ImmunoTherapy of Cancer (2019) Vol. 7, Iss. 1
Open Access | Times Cited: 256
Christine Ménétrier‐Caux, Isabelle Ray‐Coquard, Jean‐Yves Blay, et al.
Journal for ImmunoTherapy of Cancer (2019) Vol. 7, Iss. 1
Open Access | Times Cited: 256
The IL-2 cytokine family in cancer immunotherapy
Geok Choo Sim, Laszlo Radvanyi
Cytokine & Growth Factor Reviews (2014) Vol. 25, Iss. 4, pp. 377-390
Closed Access | Times Cited: 246
Geok Choo Sim, Laszlo Radvanyi
Cytokine & Growth Factor Reviews (2014) Vol. 25, Iss. 4, pp. 377-390
Closed Access | Times Cited: 246
Constitutive Signaling from an Engineered IL7 Receptor Promotes Durable Tumor Elimination by Tumor-Redirected T Cells
Thomas Shum, Bilal Omer, Haruko Tashiro, et al.
Cancer Discovery (2017) Vol. 7, Iss. 11, pp. 1238-1247
Open Access | Times Cited: 242
Thomas Shum, Bilal Omer, Haruko Tashiro, et al.
Cancer Discovery (2017) Vol. 7, Iss. 11, pp. 1238-1247
Open Access | Times Cited: 242
Stage-dependent alterations of the serum cytokine pattern in colorectal carcinoma
Tiina Kantola, Kai Klintrup, Juha P. Väyrynen, et al.
British Journal of Cancer (2012) Vol. 107, Iss. 10, pp. 1729-1736
Open Access | Times Cited: 230
Tiina Kantola, Kai Klintrup, Juha P. Väyrynen, et al.
British Journal of Cancer (2012) Vol. 107, Iss. 10, pp. 1729-1736
Open Access | Times Cited: 230